Healthcare provider profile · identity verified

Stacey Watson

Internal Medicine · RICHLAND, MI · NPI 1003926049

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	496	145
Levothyroxine Sodium	Levothyroxine Sodium	429	112
Metoprolol Succinate	Metoprolol Succinate	277	75
Lisinopril	Lisinopril	235	65
Amlodipine Besylate	Amlodipine Besylate	227	71
Omeprazole	Omeprazole	217	59
Losartan Potassium	Losartan Potassium	202	66
Metformin Hcl	Metformin Hcl	191	60
Rosuvastatin Calcium	Rosuvastatin Calcium	172	48
Simvastatin	Simvastatin	139	39
Pantoprazole Sodium	Pantoprazole Sodium	137	35
Gabapentin	Gabapentin	123	26
Tamsulosin Hcl	Tamsulosin Hcl	113	33
Sertraline Hcl	Sertraline Hcl	111	24
Ozempic	Semaglutide	107	21
Trazodone Hcl	Trazodone Hcl	101	29
Potassium Chloride	Potassium Chloride	96	23
Hydrochlorothiazide	Hydrochlorothiazide	94	29
Alendronate Sodium	Alendronate Sodium	87	20
Metoprolol Tartrate	Metoprolol Tartrate	81	22
Furosemide	Furosemide	78	23
Allopurinol	Allopurinol	77	16
Quetiapine Fumarate	Quetiapine Fumarate	77	14
Escitalopram Oxalate	Escitalopram Oxalate	74	17
Metformin Hcl Er	Metformin Hcl	74	21
Ezetimibe	Ezetimibe	71	17
Fluticasone Propionate	Fluticasone Propionate	69	23
Citalopram Hbr	Citalopram Hydrobromide	68	13
Alprazolam	Alprazolam	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	65	25
Januvia	Sitagliptin Phosphate	64	15
Pravastatin Sodium	Pravastatin Sodium	64	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	63	15
Duloxetine Hcl	Duloxetine Hcl	62	17
Venlafaxine Hcl Er	Venlafaxine Hcl	61	11
Atenolol	Atenolol	59	12
Jardiance	Empagliflozin	59	13
Meloxicam	Meloxicam	57	19
Pregabalin	Pregabalin	57	suppressed
Buspirone Hcl	Buspirone Hcl	56	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	16
Clopidogrel	Clopidogrel Bisulfate	54	19
Famotidine	Famotidine	51	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	14
Amoxicillin	Amoxicillin	50	38
Bupropion Hcl Sr	Bupropion Hcl	48	suppressed
Bupropion Xl	Bupropion Hcl	45	12
Carvedilol	Carvedilol	45	12
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	40
Tramadol Hcl	Tramadol Hcl	44	13
Xarelto	Rivaroxaban	44	suppressed
Clonazepam	Clonazepam	43	suppressed
Fenofibrate	Fenofibrate	41	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Raloxifene Hcl	Raloxifene Hcl	40	15
Eliquis	Apixaban	39	13
Glimepiride	Glimepiride	38	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	17
Montelukast Sodium	Montelukast Sodium	37	11
Spironolactone	Spironolactone	37	12
Amitriptyline Hcl	Amitriptyline Hcl	36	11
Solifenacin Succinate	Solifenacin Succinate	36	suppressed
Torsemide	Torsemide	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	34	31
Finasteride	Finasteride	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Azithromycin	Azithromycin	32	29
Methylprednisolone	Methylprednisolone	32	31
Warfarin Sodium	Warfarin Sodium	32	suppressed
Celecoxib	Celecoxib	31	12
Prednisone	Prednisone	31	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Estradiol	Estradiol	28	11
Trulicity	Dulaglutide	28	suppressed
Glipizide Er	Glipizide	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Topiramate	Topiramate	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	12
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Fluconazole	Fluconazole	18	12
Colchicine	Colchicine	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Glipizide	Glipizide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Nystatin	Nystatin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	13
Valsartan	Valsartan	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Baclofen	Baclofen	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Caplyta	Lumateperone Tosylate	13	suppressed
Cephalexin	Cephalexin	13	12
Mounjaro	Tirzepatide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Protonix	Pantoprazole Sodium	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error